Navigation Links
New Mount Sinai research tracks effects of addictive drugs on brain
Date:5/16/2008

Mount Sinai researchers may have unlocked the key to better understanding the effect addictive drugs have on the human brain. Researchers have just published the new breakthrough study, Design Logic of a Cannabinoid Receptor Signaling Network that Triggers Neurite Outgrowth, in the latest issue of Science on May 16th, 2008.

The research findings give us a new window into the brain, helping us to better understand the role addictive drugs have on the inner workings of brain cells , said Ravi Iyengar Ph.D., study author and Dorothy H. and Lewis Rosenstiel Professor and Chair, Department of Pharmacology and Systems Therapeutics at Mount Sinai School of Medicine. This type of research provides may clues for targets within brain cells against which drugs that block addiction may be targeted.

Mount Sinai researchers looked at the systems biology approach in order to study molecular networks underlying addiction. The findings start to unravel the complex interactions within brain cells, which are involved in processing signals from receptors in the brain that recognize the addictive drugs. Researchers discovered that a drug that works through the cannabinoid 1 receptor recognizing the active ingredient of marijuana activates many different transcription factors, triggering the differentiation of neurons, causing permanent changes in a persons brain. Another result of study was the discovery of a new role of the breast cancer gene BRCA 1 in neuronal differentiation and the effects of addictive drugs upon them.


'/>"/>

Contact: Mount Sinai Newsroom
newsmedia@mssm.edu
212-241-9200
The Mount Sinai Hospital / Mount Sinai School of Medicine
Source:Eurekalert

Page: 1

Related medicine news :

1. U.S. Air Force Pays Record Amount for Baby Injured in Government Hospital
2. James Chippendale Climbs the Mountain of Life
3. U of M study: Online intervention paramount for reducing HIV in high-risk population
4. New nanotube sensor can continuously monitor minute amounts of insulin
5. The Rocky Mountain Hospital for Children at Presbyterian/St. Lukes is now Member of the Childrens Oncology Group
6. RIVAs Cutting Edge Technology To Help Intermountain Healthcare Enhance Medication Delivery Safety
7. Jury Awards Mount Vernon Man $40.1 Million After Medical Device Chars Heart
8. Sharing Miracles Television Program to Feature Mountain Climber and Cancer Survivor Sean Swarner
9. Keane Wins Revenue Cycle Management Implementation With Mount Sinai Hospital of Queens
10. OrthoLite Joins the Teva U.S. Mountain Running Team
11. Aegis Therapies and Rocky Mountain University of Health Professions Announce Scholarship Recipients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2017)... New York (PRWEB) , ... ... ... Courier, LLC, d/b/a Quick International, LLC (“Quick”), a highly specialized asset-light logistics ... it has entered into a definitive agreement to purchase Unitrans International Corporation, ...
(Date:8/18/2017)... ... August 18, 2017 , ... Mediaplanet today announces ... active, healthy lifestyles and highlighting the importance of proactive eye and ear health. ... shares the latest innovations in hearing aid technology. , In this issue, ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... and financial consultations to communities throughout the greater DC region, is inaugurating a ... goal of rescuing local animals and training them to be companions for veterans ...
(Date:8/18/2017)... ... August 18, 2017 , ... MLM ... that serves communities throughout southern Florida, is working to support the Take Stock ... children from low income families. , The Take Stock In Children Foundation (TSC) ...
(Date:8/18/2017)... Bedford, TX (PRWEB) , ... August 18, 2017 , ... ... serves communities in the Dallas/Fort Worth area, is spearheading a regional charity campaign organized ... her husband. , In early June of this year, Christina and her children returned ...
Breaking Medicine News(10 mins):
(Date:7/28/2017)... 2017 Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: HRC), ... ended June 30, 2017, and updated its financial outlook ... For the fiscal third quarter, Hill-Rom reported earnings ... diluted share in the prior-year period. These results reflect ... diluted share primarily related to the non-cash write-down of ...
(Date:7/27/2017)... July 27, 2017  West Pharmaceutical Services, Inc. (NYSE: ... for the second-quarter 2017 and updated financial guidance for ... Second-Quarter 2017 Highlights Reported net sales ... the prior-year quarter. Net sales at constant currency (organic) ... EPS was $0.51, compared to $0.60 in the prior-year ...
(Date:7/26/2017)... , July 26, 2017 Sancilio Pharmaceuticals Company, ... our clinical trial evaluating Altemia TM , an oral ... and Sickle Cell Disease (SCD). The SCOT Trial, is ... efficacy and safety of Altemia TM in pediatric ... under US IND 125274. ...
Breaking Medicine Technology: